53岁千亿“果链”龙头独董病逝

Core Viewpoint - Recently, Lens Technology announced the unfortunate passing of independent director Xie Zhiming due to illness, which has led to a reduction in the board members from seven to six, below the required number as per the company's articles of association [1][3]. Group 1: Company Overview - Lens Technology specializes in the production, assembly, and support of various structural and functional components, including glass, sapphire, ceramics, metals, plastics, touch modules, biometric systems, and acoustic components [4]. - The company was listed on the Shenzhen Stock Exchange in 2015 and has applied for a main board listing on the Hong Kong Stock Exchange as of March 31, 2025 [4]. Group 2: Business Developments - As one of the "three giants" in the Apple supply chain, the company is gradually reducing its dependence on Apple by exploring new business layouts, including humanoid robots [4]. - In early November, Lens Technology received inquiries from 226 institutions, focusing on the expected shipment volume and revenue scale of its humanoid robot business [4]. - The company anticipates shipping thousands of humanoid robots and over ten thousand quadruped robotic dogs this year, with preliminary revenue estimates from the robotics business reaching several hundred million yuan [4]. Group 3: Financial Performance - In the first three quarters of this year, Lens Technology achieved a revenue of 53.663 billion yuan, representing a year-on-year growth of 16%, while the net profit attributable to shareholders was 2.843 billion yuan, up 20% year-on-year [5]. - As of December 1, the company's stock price was 28.66 yuan per share, with a market capitalization of 149.7 billion yuan [6].